GENNEX LABORATORIES
Back to Balance Sheet
|
GENNEX LABORATORIES Last 5 Year Contingent Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹0.98 Cr | ₹0.98 Cr | - | ₹0.74 Cr | ₹1.70 Cr |
What is the latest Contingent Liabilities ratio of GENNEX LABORATORIES ?
| Year | Contingent Liabilities |
|---|---|
| Mar2025 | ₹0.98 Cr |
| Mar2024 | ₹0.98 Cr |
| Mar2023 | - |
| Mar2022 | ₹0.74 Cr |
| Mar2021 | ₹1.70 Cr |
How is Contingent Liabilities of GENNEX LABORATORIES Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹0.98 Cr | 0.00 | |
| Mar2024 | ₹0.98 Cr | 0 | |
| Mar2023 | - | -100.00 | |
| Mar2022 | ₹0.74 Cr | -56.70 | |
| Mar2021 | ₹1.70 Cr | - | |
Compare Contingent Liabilities of peers of GENNEX LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GENNEX LABORATORIES | ₹268.2 Cr | -6.6% | 15.6% | -0.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹441,958.0 Cr | -3% | -5.2% | 17.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹247,576.0 Cr | 0.2% | 9.7% | 56.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹189,233.0 Cr | 1.3% | 2% | 36.5% | Stock Analytics | |
| CIPLA | ₹110,273.0 Cr | -2.2% | -6.6% | -10.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹96,906.4 Cr | 1.4% | -3.7% | -8.8% | Stock Analytics | |
GENNEX LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GENNEX LABORATORIES | -6.6% |
15.6% |
-0.5% |
| SENSEX | -2.3% |
-4.1% |
-7.4% |
You may also like the below Video Courses